← Leaderboards
Mila De Moura Behar Pontremoli Salcedo
Tulane University Of Louisiana
$417,053
Attributed
$1,251,158
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $643.4K · FY2024–25$1M$750K$500K$250K$0
'24
'25
Funding mix
By agency
NIH$1,251,158 · 1
By mechanism
U01$1,251,158 · 1
Top collaborators
- D. Troy Moon3 shared
- Jahit Sacarlal3 shared
Most similar at Tulane University Of Louisiana
Same institution · by research overlap
- Valerie Andrea Paz-Soldan$6,098,506
- Russell Barrett Van Dyke$24,377,705
- Ellen L Zakris$642,522
- Jennifer Erin Cameron$1,314,289
- Dawn M. Wesson$2,632,615
Others in their field
Other Rising Stars on “Acetic Acids”
- Nicholas Collins · Weill Medical Coll Of Cornell Univ$1,536,027
- Wenchao Qu · State University New York Stony Brook$1,416,275
- Grace Marie Jones · Touro University Of California$1,237,284
- Cesaltina Ferreira Lorenzoni · University Of Tx Md Anderson Can Ctr$1,227,195
- Jeongim Kim · University Of Florida$1,138,854
- Guofang Zhang · Coriell Institute For Medical Research$1,108,276
Research focus
Acetic AcidsAcquired Immunodeficiency SyndromeAfrica South Of The SaharaAgedCancer ControlCancer DetectionCare SystemsCaringCervicalCervical Cancer ScreeningCessation Of LifeClassificationClinical CareCold TherapyCollectionConsolidated Framework For Implementation ResearchCountryDeath RateDesignDetection SensitivityEarly TreatmentEducational WorkshopEffectiveness EvaluationAblation
Grant awards (3)
A hybrid type III effectiveness-implementation, pragmatic intervention trial for cervical cancer screen and treat in Mozambique$393,521
U01 · FY2025 · CA
A hybrid type III effectiveness-implementation, pragmatic intervention trial for cervical cancer screen and treat in Mozambique$214,274
U01 · FY2025 · CA
A hybrid type III effectiveness-implementation, pragmatic intervention trial for cervical cancer screen and treat in Mozambique$643,363
U01 · FY2024 · CA